Eledon Pharmaceuticals (ELDN) Research & Development (2013 - 2026)
Eledon Pharmaceuticals' Research & Development came in at $18.23 million for Q2 2026, down 10.1% from $20.28 million a year earlier but up 6.0% from the prior quarter.
Eledon Pharmaceuticals (ELDN) Research & Development (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Eledon Pharmaceuticals reported Research & Development of $70.67 million, up 3.5% year-over-year; for FY2024, it came in at $51.96 million, up 71.4% from FY2023.
- Research & Development has increased in each of the last four years, with a five-year compound annual growth rate of 44.9% (FY2019 to FY2024).
- Going back by year, Research & Development was $30.31 million in FY2023 (+11.9%), $27.08 million in FY2022 (+14.1%), $23.74 million in FY2021 (+287.1%) and $6.13 million in FY2020 (-24.6%).
- The five-year range for quarterly Research & Development is $5.74 million (Q2 2022) to $20.28 million (Q2 2025).
- Year-over-year, Research & Development increased in five of the last seven quarters, with growth averaging 64.7%.
- The fastest year-over-year change in Research & Development over five years came in Q4 2024 (growth of 153.7%), and the weakest in Q2 2026 (a decline of 10.1%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Eledon Pharmaceuticals | 299.99 Mn | 299.99 Mn | - | 18.23 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.23 Mn |
| Mar 31, 2026 | 17.20 Mn |
| Sep 30, 2025 | 14.97 Mn |
| Jun 30, 2025 | 20.28 Mn |
| Mar 31, 2025 | 13.53 Mn |
| Dec 31, 2024 | 17.93 Mn |
| Sep 30, 2024 | 16.52 Mn |
| Jun 30, 2024 | 10.11 Mn |
| Mar 31, 2024 | 7.41 Mn |
| Dec 31, 2023 | 7.07 Mn |
| Sep 30, 2023 | 7.93 Mn |
| Jun 30, 2023 | 7.20 Mn |
| Mar 31, 2023 | 8.11 Mn |
| Dec 31, 2022 | 7.25 Mn |
| Sep 30, 2022 | 7.45 Mn |
| Jun 30, 2022 | 5.74 Mn |
| Mar 31, 2022 | 6.64 Mn |
| Dec 31, 2021 | 6.18 Mn |
| Sep 30, 2021 | 7.66 Mn |
| Jun 30, 2021 | 4.24 Mn |
Eledon Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ELDN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ELDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ELDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();